This week, we’re reading about restrictions on GLP-1 compounding, mifepristone developments in the courts, and insurance gaps for a useful HIV prevention treatment, among other topics.
- Pharmacy Times: FDA Moves to Permanently Close the Door on Compounded GLP-1s
- Associated Press: Supreme Court restores access to abortion pill mifepristone through telehealth, mail and pharmacies
- GI & Hepatology News: GLP-1s found to outperform surgery for cirrhosis
- Reuters: Use of Gilead's HIV prevention shot rises, but US insurance gaps remain
- USA Today: As the estrogen patch shortage continues, these women are meeting with the FDA
- Drug Topics: Why Pharmacy Schools Are Urged to Partner with Community Pharmacies
- Merced Sun-Star: Walgreens shuts hundreds of stores as protests grow
- SDBP: South Dakota receives $10 million in Purdue Pharma settlement
- Fox 48: Senator Bill Cassidy visits Lafayette to address rising prescription drug costs
- KREX: Rural Colorado pharmacies face under-reimbursement crisis
- WYFF: Patients, locally owned pharmacies struggle with the growing pains of soaring drug costs
NCPA
